Wu et al. demonstrated that the loss of RBMS3 in epithelial ovarian cancer not only induced chemoresistance to platinum but also promoted recurrence via miR-126-5p/β-catenin/CBP signalling. Here, RBMS3 is linked to ovarian carcinoma.